Mumbai: Niva Bupa Health Insurance has announced key leadership changes following the approval of its Board of Directors at a meeting held on May 8, 2026, in line with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has elevated Ankur Kharbanda to the position of Executive Director and Deputy Chief Executive Officer with immediate effect from May 8, 2026. Kharbanda was previously serving as Executive Director and Chief Business Officer at the company.
In addition, the Board has approved the appointment of Christopher Patrick Carroll as an Additional Director in the category of Non-Executive Director, effective May 15, 2026, subject to shareholder approval within three months from the date of appointment.
The company has also appointed Siobhan Djihan Moynihan as an Additional Director in the category of Non-Executive Director, effective May 15, 2026, subject to shareholder approval within the stipulated timeline.
The appointments and elevation were approved based on the recommendation of the Nomination & Remuneration Committee.
In its filing to the National Stock Exchange of India and BSE Limited, the company confirmed that Christopher Patrick Carroll and Siobhan Djihan Moynihan have not been debarred from holding the office of director by SEBI or any other regulatory authority.
